lunes, 29 de julio de 2013

Five-year analysis of magnetic re... [J Med Imaging Radiat Oncol. 2013] - PubMed - NCBI

Five-year analysis of magnetic re... [J Med Imaging Radiat Oncol. 2013] - PubMed - NCBI

J Med Imaging Radiat Oncol. 2013 Aug;57(4):400-6. doi: 10.1111/1754-9485.12030. Epub 2013 Jan 14.

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.

Source

The Breast Service, The Royal Melbourne and The Royal Women's Hospitals, Melbourne, Victoria, Australia.

Abstract

INTRODUCTION:

Women at very high risk of breast cancer are recommended to undertake enhanced surveillance with annual MRI in addition to mammography. We aimed to review the performance of breast MRI as a screening modality over its first 5 years at our institution.

METHODS:

The study used a retrospective review using prospectively collected data from a consecutive series of women at high risk of developing breast cancer undergoing surveillance MRI.

RESULTS:

Two hundred twenty-three women had at least one screening MRI. The median age was 42 years old. Sixty-nine (30.9%) were confirmed genetic mutation carriers. The remaining 154 (69.1%) women were classified as high risk based on family history, without a confirmed genetic mutation. Three hundred forty screening MRI studies were performed. Of these, 69 patients (20.3%) were recalled for further assessment. There was a significant reduction in the recall rate throughout the study for prevalent screens, from 50% (17/34) in 2008 to 14% (9/54) in 2011 (P = 0.004). The overall biopsy rate was 39 in 340 screens (11.5%). Four cancers were identified. Three were in confirmed BRCA1/BRCA2 mutation carriers, and one was found to be a carrier after the cancer was diagnosed. All four were identified as suspicious on MRI, with two having normal mammography. The cancer detection rate of MRI was 1.2% (4/340 screens). The overall positive predictive value was 7.0%, 6.7% for prevalent screens and 7.1% for subsequent screens.

CONCLUSIONS:

Breast MRI as a screening modality for malignant lesions in women with high hereditary risk is valuable. The recall rate, especially in the prevalent round, improved with radiologist experience.
© 2013 The Authors. Journal of Medical Imaging and Radiation Oncology © 2013 The Royal Australian and New Zealand College of Radiologists.

KEYWORDS:

breast, cancer, imaging, magnetic, screening
PMID:
23870334
[PubMed - in process]

No hay comentarios:

Publicar un comentario